2 days BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now? Zacks

   X     

2 days Here’s Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock Zacks

   X     

6 days BioMarin Pharmaceuticals: Share Downdraft Combined With VOXZOGO Potential Makes A Buy Seeking Alpha

   X     

6 days Zacks.com featured highlights include BioMarin, Amazon.com, Leidos and The Ensign Zacks

   X     

1 week Here is Why Growth Investors Should Buy BioMarin (BMRN) Now Zacks

   X     

2 weeks Zacks Industry Outlook Highlights Incyte, BioMarin, Exelixis, Halozyme and Blueprint Medicines Zacks

   X     

2 weeks Wall Street Analysts Predict a 45.86% Upside in BioMarin (BMRN): Here’s What You Should Know Zacks

   X     

2 weeks Here’s Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock Zacks

   X     

3 weeks Here’s Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock Zacks

   X     

4 weeks 3 Reasons Why Growth Investors Shouldn’t Overlook BioMarin (BMRN) Zacks

   X     

4 weeks BMRN or TECH: Which Is the Better Value Stock Right Now? Zacks

   X     

1 month Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term Zacks

   X     

1 month Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term Zacks

   X     

1 month Is the Options Market Predicting a Spike in BioMarin Pharmaceutical (BMRN) Stock? Zacks

   X     

2 months BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy? Zacks

   X     

2 months Why Is BioMarin (BMRN) Down 1.9% Since Last Earnings Report? Zacks

   X     

2 months Biomarin: Challanges Mount, But Sale Rumours Make For A Risky “Buy” Call Seeking Alpha

   X     

2 months Here’s Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock Zacks

   X     

2 months Here’s Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock Zacks

   X     

3 months Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think “Yes” Zacks

   X     

3 months BioMarin (BMRN) Upgraded to Buy: Here’s Why Zacks

   X     

3 months BMRN vs. INCY: Which Stock Is the Better Value Option? Zacks

   X     

3 months Earnings call: BioMarin reports robust Q3 growth with VOXZOGO sales surge Investing.com

   X     

3 months Royal Bank of Canada Reiterates “Sector Perform” Rating for BioMarin Pharmaceutical (NASDAQ:BMRN) MarketBeat

   X     

3 months BioMarin Q3 Earnings & Revenues Beat Estimates, ’24 Guidance Raised Zacks

   X     

3 months BioMarin Pharmaceutical Inc. (BMRN) Q3 2024 Earnings Call Transcript Seeking Alpha

   X     

3 months BioMarin (BMRN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates Zacks

   X     

3 months BioMarin Pharmaceutical (BMRN) to Release Quarterly Earnings on Tuesday MarketBeat

   X